Urologix, Inc.

Equities

ULGX

US9172731047

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 09:48:12 2024-03-08 EST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-.--%

2016	A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	CI
2015	Urologix Conducting A Strategic Review	CI

Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance

January 08, 2014 at 04:00 pm

Urologix, Inc. reported revenue results for the second quarter ended December 31, 2013. Second quarter fiscal year 2014 revenue totaled $3.8 million, up 1% compared to the first quarter of fiscal year 2014 and down 13% compared to the prior year's results.

As of the result of the strategic restructuring, the Company has elected to withdraw its previously issued fiscal year 2014 revenue guidance.

Latest news about Urologix, Inc.

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	16-02-01	CI
Urologix Conducting A Strategic Review	15-07-09	CI
Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015	15-05-12
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	15-05-12	CI
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	15-03-23	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	15-02-05	CI
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015	15-02-05
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014	15-01-12	CI
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014	14-11-04
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015	14-11-04	CI
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014	14-08-19
Urologix, Inc. Announces Executive Changes	14-08-19	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015	14-08-19	CI
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	14-05-28	CI
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014	14-05-06
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	14-05-06	CI
Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014	14-04-10	CI
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014	14-02-04
Urologix Secures Extension of Credit Facility	14-02-04	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013	14-02-04	CI
Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance	14-01-08	CI
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013	13-10-29
Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014	13-10-29	CI
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013	13-08-20
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013	13-08-20	CI

Chart Urologix, Inc.

Duration

Period

More charts

Company Profile

21st North Inc. is not engaged in any operating activity. The Company has dissolved.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UROLOGIX, INC.	-.--%	2.13K
DANAHER CORPORATION	+10.16%	189B
INTUITIVE SURGICAL, INC.	+26.21%	151B
BOSTON SCIENTIFIC CORPORATION	+32.78%	113B
SIEMENS HEALTHINEERS AG	+1.98%	64.02B
EDWARDS LIFESCIENCES CORPORATION	+14.48%	52.6B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.92%	49.85B
AGILENT TECHNOLOGIES, INC.	-6.60%	37.89B
GE HEALTHCARE TECHNOLOGIES INC.	-1.07%	34.92B
RESMED, INC.	+23.08%	31.1B

Other Advanced Medical Equipment & Technology